News

Client News KAUST startup Lihytech raises $6 million to extract lithium from seawater 2nd February 2023 Client News Watson-Marlow to create biodiverse native woodland in Ireland 15th December 2022 Client News NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture 15th December 2022 Client News Client News BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis 8th December 2022 Client News MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease 6th December 2022 Client News Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022 5th December 2022 Client News Client News BRIM Biotechnology, Inc. raises $20 million in Series E funding round 1st December 2022 Client News Gelomics Partners With Rousselot Biomedical to Create the World’s First, Ready-to-Use 3D Cell Culture Kits Based on X-PURE® GelMA 16th November 2022 Client News Domainex expands Executive and Management Teams to support ongoing growth 15th November 2022 Client News Client News BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting 1st November 2022